Pop Health Tech

“It’s a powerful tool...You can literally build an app in an hour and publish it,” Brian Well said.

The language regarding EMRs and MACRA at large was fairly straightforward during a panel at the Philadelphia HIT Summit.

The findings are particularly relevant in light of the 21st Century Cures Act implemented last December and the Right to Try Act approved by the Senate last week.

Predictive modeling may add a layer of protection against the common virus.

The firms utilized everything from novel devices to advanced analytics to dogs.

Critics argue that the law could have negative effects on the clinical trial process.

The CEO and CMO of SidekickHealth give a deep, detailed look at the development and potential of mobile apps that could change how patients approach their chronic conditions.

Value-based care is not necessarily cheap. A new MIT study finds that hospitals more reliant on outpatient nursing facilities often yield higher mortality rates.

In published documents and a detailed blog post from its Commissioner, the FDA made public its plans for using data modelling to improve regulatory trials.

The company's DeepMind subsidiary and the UK's Royal Free health system may not have done enough to inform patients their data was in use. The two are working to develop an alert application to analyze risk of kidney disease.

“With telemedicine, distance is no longer an impediment to receiving health care services from anywhere in Pennsylvania or across the country,” says State Senator Elder Vogel.

Experts compare existing paging methods within hospitals to "paved cowpaths."

"If this were a drug that had a survival advantage of this magnitude, it would be retail priced at hundreds of thousands of dollars."

Recent reports of a new team at the FDA that will try to match healthtech's pace of innovation mesh with previous writings by the Administration's recently-appointed head, Scott Gottlieb.

When it was a mere "online bookseller," Amazon invested in 40% of an online pharmacy that didn't quite pan out. Now the preeminint online retail giant, the company is believed to be taking another look at the complex industry.

SCIO Health Analytics' Chief Evangelist argues for the use of analytics to prevent complications and provide true value-based care.

Partnership of major national companies launches initiative, encourages President in pursuit of wider adoption of value-based models.

electroCore's device provides mild electrical stimulation to the vagus nerve in order to alleviate headaches.

The Project ECHO programs in New Mexico seek to use mass specialist-to-primary teleconferencing to improve treatment of conditions like diabetes across a vast, rural state.

Equipped with the pancreas and a Fitbit, the children successfully maintained good blood sugar levels despite elevated activity.

A House of Representitives vote on the American Health Care Act did not fall on the seventh anniversary of the signing of the Affordable Care Act. Now it will not occur at all.

The review included nearly 30,000 young patients and found a "small, but significant" effect of mHealth as a viable modality in their treatment.

In the second part of our interview with CCHP director Gutierrez, he speaks about how telehealth policy is evolving nationwide.

Respected surgeon pens plea in Annals of Surgery urging increased use of electronic prescribing platforms to stem the tide of opiate misuse.

"It’s a constant theme we'll be talking about continuously," Hart says. "Patients are saying "we need this support" and yet very few providers are delivering it. "

New Enterprise Associates boasts a portfolio with more than an alphabet's worth of drug makers and research firms in the fold. It also might boast the new head of the Food and Drug Administration.

In the final interview installment, David Engelhardt of ReadyDock Inc., speaks of how the company’s collaboration with Samsung can clean a device of bacteria and data alike.

In Part 2 of his interview with HCA News, David Engelhardt, the founder of ReadyDock Inc., discussed the company's chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. Here, Engelhardt details how ReadyDock’s technology works and infection-causing bacteria it can kill.

David Engelhardt, the founder of ReadyDock Inc., met up with HCA News for an interview at the HIMSS17 conference in Orlando, Florida. ReadyDock is chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. In this section, Engelhardt speaks of the severity and complexity of the infection issue.